Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2020 to date.

 
USA

10x Genomics

 
 
Australia

360Biolabs

 
 
USA

3E Bioventures

 
 
United Kingdom

4BIO Capital

 
 
USA

6 Dimensions Capital

 
USA

A6 Pharmaceuticals LLC

 
 
USA

Aagami, Inc.

 
 
USA

A-Alpha Bio

 
 
USA

Aberdeen Investment Management

 
 
USA

ABES Venture Partners

 
 
USA

Abimmune Biopharma

 
United Kingdom

Abzena Limited (Cambridge)

 
USA

Acasti Pharma

 
Singapore

Accelerate Technologies Pte Ltd

 
 
Canada

Accel-Rx Health Sciences Accelerato

 
USA

Access Vascular

 
Japan

AccuRna Inc

 
 
USA

Acepodia

 
 
USA

Aceras Partners

 
France

ACTICOR BIOTECH

 
 
USA

Actinium Pharmaceuticals Inc

 
USA

Adjuvance Technologies

 
 
USA

Aegis Capital Corp.

 
 
Germany

aescuvest.eu

 
 
USA

Affinity Growth Advisors

 
 
Japan

Aflac Innovation Partners G.K.

 
 
USA

Agent Capital

 
USA

Agenus

 
 
USA

AgeX Therapeutics, Inc.

 
 
USA

Agile Therapeutics

 
 
USA

Agilent Technologies Inc

 
Australia

Agilex Biolabs

 
 
Netherlands

Aglaia Management B.V.

 
Spain

Ahead Therapeutics

 
 
USA

AiM Medical Robotics

 
Japan

Ajinomoto Co Inc

 
 
United Kingdom

Albion Capital

 
USA

Albumedix

 
United Kingdom

Albumedix Ltd

 
USA

ALEON PHARMA INTERNATIONAL

 
 
USA

Alignment Ventures

 
 
USA

Alira Health

 
 
USA

AllerGenis

 
USA

Alliance for Cancer Gene Therapy

 
USA

Alloy Therapeutics

 
USA

Alnylam

 
 
Israel

Alpha Tau Medical Ltd.

 
 
USA

AlphaSense, Inc.

 
 
USA

Alpine BioVentures GP LLC

 
 
Spain

Alta Life Sciences

 
USA

Alteogen Inc.

 
Australia

Alterity Therapeutics Limited

 
USA

AltPep Corporation

 
 
USA

AltrixBio

 
France

ALZPROTECT PHARMA

 
 
USA

American Business TV

 
USA

Amivas LLC

 
 
Canada

AmorChem

 
Netherlands

Amphera BV

 
 
USA

Amplity Health

 
Japan

AnGes, Inc.

 
 
USA

Angex Pharmaceutical Inc

 
 
United Kingdom

Angle Plc

 
 
USA

Anima Biotech Inc

 
 
USA

Anixa Biosciences, Inc.

 
Sweden

Anocca AB

 
 
USA

Anokion

 
Denmark

Antag Therapeutics

 
Canada

Antibe Therapeutics Inc

 
 
USA

Antiva Biosciences

 
Austria

Apeiron Cell Therapies GmbH (ACellT)

 
 
United Kingdom

Apex Healthcare Consulting

 
USA

Apollo Life Science Partners

 
 
Germany

Apollo Ventures

 
 
USA

Aptose Biosciences

 
 
USA

Aqua Partners LLC

 
 
USA

Aqualung Therapeutics, Corp

 
USA

Aquestive Therapeutics

 
 
USA

Arch Therapeutics

 
USA

Aristea Therapeutics, Inc.

 
USA

Arizona Bioindustry Association, In

 
 
USA

Arizona Tech Investors

 
 
USA

Arkitekt Ventures

 
 
United Kingdom

Arrowfield Capital

 
 
USA

Asahi Kasei America Inc

 
 
USA

Ascendiant Capital Fund LP

 
 
Belgium

ASIT Biotech

 
 
France

Asklepios Advisors

 
Japan

Astellas Pharma Inc

 
 
USA

Astellas Rx

 
 
USA

Astia Angels

 
 
United Kingdom

Astrazeneca

 
 
Sweden

AstraZenenca

 
 
USA

ATCC

 
 
China

Atom Bioscience and Pharmaceutical

 
 
USA

Atomwise

 
Germany

Atriva Therapeutics GmbH

 
 
USA

AuGC Partners

 
 
USA

AuntMinnie.com

 
USA

Auransa Inc

 
India

Aurigene Discovery Technologies Ltd

 
 
Japan

Aurora Partners K.K.

 
United Kingdom

Avacta Life Sciences

 
USA

Avammune Therapeutics Inc

 
 
Australia

Avance Clinical Pty Ltd

 
 
Ireland

Avectas Ltd

 
USA

Avisa Pharma

 
 
USA

AvroBio

 
 
USA

AzurRx BioPharma

 
 
USA

Bachem Americas Inc

 
 
USA

Back Bay Life Science Advisors

 
 
USA

Baker McKenzie

 
France

BALMES TRANSPLANTATION

 
United Kingdom

Barrington James

 
 
Germany

Bayer AG

 
 
Switzerland

Bayer Consumer Care AG

 
USA

Bayer Healthcare LLC

 
USA

Baylor Scott & White Research Institute

 
 
USA

BDO

 
Germany

Beoro Therapeutics GmbH

 
 
Japan

Beyond Next Ventures

 
 
USA

Big43Bio

 
 
USA

BIMA Capital, LLC

 
 
USA

BIO

 
 
India

Bio Ideations LLP

 
 
Australia

Bioasis Technologies, Inc.

 
 
USA

Biobridge Global

 
 
Australia

BioCapital Impact Fund

 
 
USA

Biocom

 
USA

Biodesy Inc

 
USA

BioGraphene Inc.

 
 
USA

BioHealth Innovation

 
 
Sweden

BioInvent International AB

 
Spain

Biokit Research & Development S L U

 
Canada

Biolab Pharma

 
 
Lithuania

Biomapas

 
 
USA

BioMarker Strategies, LLC

 
 
Switzerland

BioMedPartners AG

 
 
USA

BioNJ Inc

 
Australia

Bionomics Ltd

 
South Korea

Bionoxx

 
 
South Korea

Bionoxx Inc.

 
 
Germany

BioNTech SE

 
 
Spain

Bionure Farma

 
 
USA

BioPharma Global Inc.

 
 
Belgium

Bioqube Ventures

 
 
USA

BioQuest

 
 
USA

BioSense Global LLC

 
USA

Biospecifics Tech Corp

 
 
USA

Biospherics.net

 
 
France

Biotech Finances

 
 
USA

Biotech Investment Group

 
China

Bio-Thera Solutions

 
 
USA

BioValleyCHINA Ventures

 
 
USA

BioWorld

 
United Kingdom

Black Belt Tx

 
 
Israel

Body Vision Medical

 
 
USA

Boehringer Ingelheim Biopharmaceuticals GmbH

 
 
China

BOHE Angel Fund

 
 
Germany

Boltendahl International Partners

 
 
Netherlands

BOM Capital II B.V.

 
South Korea

Boryung Pharmaceutical Co Ltd

 
 
USA

Boston Healthcare Associates

 
 
France

Bpifrance Investissement

 
 
USA

Brace Pharma Capital

 
 
USA

Brain Trust Bio

 
 
USA

Brainstorm Cell Therapeutics

 
 
USA

Brandon Capital Partners

 
 
USA

BriaCell Therapeutics Corp

 
 
USA

Bridge Valley Ventures

 
 
USA

Bridle Path Investments Inc.

 
China

Briiliant Pharma

 
 
USA

Broadview Ventures

 
 
USA

Brookline Capital Markets

 
 
USA

BryoLogyx Inc

 
 
USA

Business France

 
USA

Buto Corporation

 
USA

BW Therapeutics

 
 
USA

C&EN

 
 
USA

C3 Research Associates

 
 
USA

Caladrius Biosciences, Inc.

 
 
USA

California Israel Chamber Of Commer

 
 
USA

California Life Sciences Association

 
USA

California Life Sciences Institute

 
 
Canada

Camargo Pharmaceutical Services

 
 
United Kingdom

Cambridge Innovation Capital

 
Australia

Cancer Trials Australia

 
 
United Kingdom

Capital International Limited

 
France

Cardio Renal

 
France

CarThera

 
USA

CASI

 
USA

CASI Pharmaceuticals Inc

 
 
USA

Catalent

 
 
USA

Catalent, Inc.

 
 
USA

Cato Research

 
USA

CATX Inc

 
 
China

CD Capital

 
USA

Celata Therapeutics

 
USA

Celavie Biosciences, LLC

 
United Kingdom

Cell and Gene Therapy Catapult

 
 
USA

Cellectar Biosciences Inc

 
USA

Cello Health BioConsulting

 
 
USA

Center for Innovative Technology

 
 
Sweden

Cereno Scientific

 
 
USA

Chaperone Investment

 
 
USA

ChemioCare

 
China

ChinaBio Group

 
United Kingdom

Chronos therapeutics

 
USA

Chronus Health

 
United Kingdom

CIMYM BioSciences

 
 
USA

CincyTech

 
 
USA

Cipla New Ventures

 
 
United Kingdom

Citigate Dewe Rogerson

 
 
USA

Clarigent Health

 
 
USA

Class Bravo Ventures

 
 
USA

ClearView Healthcare Partners

 
 
USA

Cleveland Clinic Ventures

 
 
United Kingdom

Clinical Accelerator

 
 
USA

Clinical Network Services Pty. Ltd.

 
 
Singapore

Clinical Research Ventures

 
United Kingdom

Closed Loop Medicine Ltd

 
USA

ClostraBio

 
 
USA

CM Capital Corporation

 
 
China

CMAB Biopharma

 
 
Japan

CMIC HOLDINGS Co Ltd

 
United Kingdom

CN Bio Innovations Ltd

 
 
USA

Cofactor Genomics

 
 
USA

Cognoptix

 
 
USA

Connecticut Innovations

 
 
USA

Convalesce

 
 
USA

Conway Communications

 
 
Australia

CoSec Consulting

 
 
United Kingdom

Coulter Partners

 
 
USA

Covance

 
 
USA

Cove Fund II

 
 
China

Cowin Venture

 
 
USA

CPC Scientific Inc

 
USA

Creatv MicroTech, Inc.

 
USA

Crosswave Management

 
USA

Cryoport

 
South Korea

CrystalGenomics, Inc.

 
USA

CTI

 
 
Canada

CTI Life Sciences Fund

 
 
Canada

CTI Life Sciences Fund II

 
 
USA

Cultivation Capital

 
 
USA

CuRAGE Therapeutics

 
 
United Kingdom

Curileum Discovery Ltd

 
 
USA

Cybernaut Zfounder Venture

 
 
USA

Cyclacel Pharmaceuticals, Inc.

 
 
USA

CytoSorbents Corporation

 
France

Da Volterra

 
South Korea

Daewoong Bio

 
South Korea

Daewoong Pharmaceutical

 
South Korea

Daewoong Pharmaceutical Ltd.

 
USA

Daiichi Sankyo

 
 
USA

DavosPharma

 
 
South Korea

DAYLI Partners

 
 
Switzerland

Debiopharm Innovation Fund SA

 
 
China

Decheng Capital

 
USA

Decoy Biosystems, Inc.

 
USA

DEL BioPharma

 
 
China

Delian Capital

 
 
Hong Kong

Delos Capital

 
 
USA

DFA Consulting

 
 
USA

DFB Pharmaceuticals LLC

 
 
USA

DHVC

 
France

Diabeloop

 
USA

DigiTx Partners

 
USA

Diverse Biotech

 
 
Sweden

DNB Markets

 
 
USA

Dogtown Media

 
 
USA

Dolby Family Ventures

 
 
France

Domain Therapeutics

 
 
USA

Dorset Capital LLC

 
USA

Drexel University

 
USA

DrugCendR Inc.

 
 
USA

DSI

 
USA

DTx Pharma

 
USA

Dualogics

 
USA

DuPont

 
 
USA

Durbin Global

 
 
USA

Dyadic International Inc

 
Japan

DyDo Pharma Inc

 
 
United Kingdom

Dynamic Metrics

 
 
USA

Dynamk Capital

 
Japan

EA Pharma Co Ltd

 
 
Switzerland

Earlybird

 
USA

EarlyDiagnostics, Inc

 
 
USA

Easton Capital Investment Group

 
 
USA

EBD

 
 
USA

EBD Group

 
 
Germany

EBD Group GmbH

 
 
Germany

EBD Group GmbH Customer Operations

 
USA

Eccrine Systems, Inc.

 
USA

Edesa Biotech, Inc

 
 
United Kingdom

Edinburgh Molecular Imaging

 
 
USA

Edison Investment Research

 
 
Puerto Rico

EGB Ventures

 
 
China

Eight Roads Ventures

 
 
Japan

Eight Roads Ventures Japan

 
 
Denmark

Eir Ventures

 
 
USA

EisnerAmper

 
United Kingdom

Elasmogen Ltd

 
USA

Eleusis

 
 
USA

Elex Biotech

 
Japan

Elix, Inc.

 
France

ELSE CARE

 
 
USA

Emerald Development Managers LP

 
 
Australia

EnGeneIC Ltd

 
 
USA

Engine Room

 
United Kingdom

Engitix Limited

 
USA

Enteris BioPharma

 
 
USA

Enzyvant

 
USA

EOC Pharma

 
Belgium

EPICS Therapeutics

 
 
United Kingdom

Epidarex Capital

 
 
USA

EpiVax Oncology, Inc.

 
Japan

e-Projection K.K.

 
United Kingdom

ERA Consulting UK lTD

 
 
Singapore

Esco Ventures X

 
Germany

Eternygen GmbH

 
South Korea

EuBiologics Co., Ltd.

 
 
USA

Evaluate

 
 
USA

Evolution Life Science Partners

 
 
USA

Evotec

 
United Kingdom

Evotec UK Limited

 
 
USA

EXXclaim Capital

 
Netherlands

Facio Therapies

 
 
China

Fapon Capital Inc.

 
 
Hungary

FastVentures

 
 
China

FC Capital

 
Canada

Feldan Therapeutics

 
 
USA

Ferghana Partners Inc

 
USA

Ferring Research Institute Inc

 
USA

Firstlight Pharmaceuticals

 
 
USA

Flow Pharma, Inc.

 
 
USA

FMG Ventures

 
 
USA

Foley Hoag

 
Finland

Forendo Pharma Ltd.

 
 
USA

Fortunatus Capital

 
 
Ireland

Fountain Healthcare Partners

 
 
USA

FoxHill Asset Management

 
 
Canada

FSD Pharma, Inc

 
 
USA

FUJIFILM Diosynth Biotechnologies I

 
 
USA

FUJIFILM Diosynth Biotechnologies USA

 
 
Belgium

Fund+ NV

 
South Korea

G+FLAS Life Sciences, inc.

 
 
USA

G4S Capital

 
USA

Galenus Therapeutics Inc.

 
Israel

Gals Bio Ltd

 
 
Austria

GBA Group Pharma

 
South Korea

GC Pharma

 
USA

GenCure

 
 
South Korea

Generoath

 
 
Canada

Genesys Capital

 
Switzerland

GeNeuro SA

 
 
USA

Genevant Sciences Inc.

 
Netherlands

Genmab

 
 
USA

Genprex, Inc.

 
USA

GeoVax Labs, Inc.

 
 
United Kingdom

GHO Capital Partners

 
 
Germany

Gimv

 
Belgium

Gimv NV

 
France

GIP GENOPOLE

 
 
China

GL Capital

 
 
USA

GLAdiator Biosciences

 
 
USA

Glickman Family Office

 
 
USA

Global Alpha Ventures

 
 
USA

Global Source Ventures LLC

 
 
Canada

Glysantis Inc.

 
 
USA

Good Health Capital NY

 
 
USA

Gore Range Capital

 
 
USA

GPG Ventures

 
 
China

Gracell Biotechnologies

 
 
USA

Gray Strategic Advisors, LLC

 
 
USA

Great Point Partners Llc

 
 
USA

Green Park & Golf Ventures

 
 
USA

Greenberg Traurig

 
 
Italy

GreenBone Ortho

 
USA

GreenField Chemical

 
USA

GreenField Chemical, Inc.

 
 
Canada

GreenSky Capital

 
 
USA

Grey Sky Venture Partners

 
Germany

Grunenthal GmbH

 
USA

GSK Consumer Healthcare

 
 
USA

GSR Ventures

 
 
United Kingdom

GTJA Investment Group

 
Russian Fed.

Gurus BioPharm LLC

 
 
USA

H.C. Wainwright & Co.

 
 
Norway

Hadean Ventures AS

 
 
South Korea

Haim bio Co., Ltd

 
China

Haisco Pharmaceutical Ltd

 
China

Haisco Pharmaceuticals Group

 
 
USA

Halloran Consulting Group

 
 
USA

HatchBIo Fund

 
 
Puerto Rico

HAYIM Group

 
USA

Healios

 
 
Japan

HEALIOS K.K.

 
USA

HealthBeacon

 
 
USA

Healthy and Sustainable Foods

 
 
USA

Healx

 
 
United Kingdom

Healx Limited

 
 
Japan

Heartseed Inc.

 
 
USA

Helicase Venture

 
 
USA

Helix Ventures

 
 
Monaco

Helsinn

 
China

Henlius Biotech, Inc.

 
 
USA

HepQuant

 
Germany

Heraeus Holding GmbH

 
Germany

Heraeus Medical GmbH

 
 
USA

Hercules Capital

 
 
Singapore

Heritas Capital Management

 
 
Monaco

Hestia Investments Ltd.

 
 
China

Hexaell Biotech

 
USA

Hillstream BioPharma Inc.

 
China

HitGen Inc.

 
USA

Hogan Lovells

 
 
USA

Hongjing Capital

 
 
Hong Kong

Horizons Ventures

 
Australia

Hudson Institute of Medical Researc

 
 
South Korea

Hyun & Partners Korea

 
 
United Kingdom

IAG

 
 
USA

Iaso Ventures

 
Russian Fed.

Ibraco, LLC

 
 
United Kingdom

IGEM Therapeutics Ltd

 
France

IKTOS

 
 
USA

Illumina Ventures

 
 
USA

Immunexpress

 
 
USA

ImmunoMet Therapeutics

 
 
United Kingdom

Immupharma Plc

 
 
USA

Incysus Therapeutics, Inc.

 
 
Italy

Indaco Venture Partners SGR

 
France

Inflectis Bioscience

 
Switzerland

Informa IPCo

 
 
United Kingdom

InHealth Ventures

 
Denmark

Initiator Pharma

 
 
Netherlands

Inkef Capital BV

 
 
Canada

InMed Pharmacauticals Inc.

 
 
Italy

Innogest Capital

 
 
Germany

INOGROUP

 
 
USA

Inovation Ventures

 
 
USA

Inovio Pharmaceuticals

 
 
Denmark

InProTher ApS

 
France

Institut de Recherches Servier

 
 
USA

Interlaken Associates

 
Netherlands

InteRNA Technologies BV

 
USA

Interpace Diagnostics

 
 
USA

Intrommune Therapeutics

 
 
Lithuania

Invest Lithuania

 
 
Canada

Investing News Network

 
 
Denmark

IO Biotech

 
USA

Iomx Therapeutics

 
 
Germany

iOmx Therapeutics AG

 
 
USA

Ionic Ventures LLC

 
 
Amer.Virgin Is.

Ionic Ventures, LLC

 
 
Switzerland

IPF Partners

 
 
USA

IPSEN BioSciences

 
Italy

IRBM SpA

 
 
USA

IRISYS LLC

 
Puerto Rico

Isla Pharmaceuticals

 
United Kingdom

Isogenica Ltd

 
USA

iVeena Delivery Systems INC

 
Russian Fed.

IVIX Ltd

 
 
Japan

JAFCO Co Ltd

 
 
USA

JDRF T1D Fund

 
USA

Jefferson Health

 
 
China

Jiangsu Atom Bioscience and Pharmaceutical Co. Ltd.

 
 
Japan

Jiksak Bioengineering, Inc.

 
USA

Johns Hopkins Technology Ventures

 
 
USA

Johnson & Johnson

 
 
USA

Johnson & Johnson Innovation

 
 
USA

Johnson Matthey PLC

 
China

Joincare Pharmaceutical Group

 
 
USA

Joyance Partners

 
 
USA

JP Morgan

 
USA

JT Pharma

 
India

Jubilant Life Sciences Ltd

 
 
USA

Jubilant Therapeutics Inc

 
 
USA

Julz Co LLC

 
 
USA

KAER Biotherapeutics

 
 
China

Kaitai Capital

 
 
United Kingdom

KaNDy Therapeutics

 
Spain

Kantar

 
USA

Kantar Health

 
 
USA

Kapor Capital

 
USA

Karyopharm Therapeutics

 
USA

Katan Associates

 
 
Australia

Kazia Therapeutics Limited

 
 
USA

KBP Biosciences

 
France

Keen Eye Technologies

 
USA

Keystone Bio

 
 
USA

Kineticos Life Sciences

 
 
USA

Kingdom Capital

 
 
USA

Kingsford Capital Management

 
Canada

KisoJi Biotechnology

 
Israel

Kitov Pharma

 
 
USA

Kiyoizumi Advisory LLC

 
 
USA

Kleo Pharmaceuticals

 
 
USA

Koenig, Oelsner, Taylor, Schoe

 
USA

Kolon TissueGene

 
South Korea

Konyang University

 
USA

Kowa Research Institute Inc

 
Japan

Kyoto University

 
 
USA

Kyto Technology and Life Science, I

 
USA

LA BioMed

 
Spain

Laboratorios Rubio S. A.

 
 
Australia

Lachesis Biosciences Ltd

 
 
China

Laekna Therapeutics

 
 
USA

Lake Capital

 
USA

Landos Biopharma

 
USA

Lantern Pharma, Inc.

 
USA

Lassogen, Inc.

 
 
USA

Latham Biopharm Group

 
 
USA

LaVoie HealthScience

 
 
Australia

LBT Innovations

 
South Korea

LegoChem Biosciences

 
USA

Lexicon Pharmaceuticals

 
South Korea

LG Chem

 
Canada

Life Chemicals Inc.

 
 
USA

Life Science Angels

 
 
USA

Life Science Washington

 
 
United Kingdom

LifeArc

 
 
United Kingdom

LIfT BioSciences

 
 
USA

Lilly Asia Ventures

 
Portugal

Limm Therapeutics

 
 
USA

Lincoln Park Capital

 
Australia

Linear Clinical Research

 
 
Japan

LINK-J

 
USA

Lipella Pharmaceuticals Inc

 
 
Sweden

Lipidor AB

 
France

LLTech

 
United Kingdom

Locate Bio Limited

 
 
Hong Kong

Longenesis

 
 
USA

Longevity Vision Investment Advisor

 
 
USA

Lowenstein Sandler LLC

 
 
USA

Lowenstein Sandler LLP

 
 
USA

Lucy Therapeutics, Inc.

 
 
Canada

Lumira Ventures

 
 
Denmark

Lundbeckfonden Emerge

 
France

LXRepair

 
 
USA

LYFE Capital

 
 
USA

Lymo Ventures - Life Science Angels

 
France

Lyon Biopole

 
 
Netherlands

M Ventures BV

 
 
France

MaaT Pharma

 
 
USA

MabPlex USA Inc

 
USA

MAIA Biotechnology Inc

 
 
USA

MaidStone Life Sciences

 
 
USA

Maple Leaf Partners

 
 
USA

Mariam Global Health LLLP

 
Japan

Maruho Co Ltd

 
 
USA

Maryland Life Sciences

 
 
USA

Massachusetts Biotechnology Council

 
 
USA

MBio Diagnostics

 
 
Japan

MBL Venture Capital Co., Ltd.

 
USA

MD2 Biosciences Inc

 
USA

Medexus Pharma, Inc.

 
 
USA

Medical Marketing Economics LLC

 
France

Medincell

 
 
South Korea

Medivate Partners

 
 
USA

Medmarc

 
 
USA

MedTech Innovator

 
France

Meersens

 
USA

Mekanistic Therapeutics, LLC

 
 
USA

Melior Pharmaceuticals

 
Switzerland

Memo Therapeutics AG

 
 
USA

Merck

 
USA

Merck and Co

 
USA

Merck Sharp & Dohme Corp

 
 
USA

MergerMarket Acuris Group

 
 
USA

Mesa Verde Venture Partners

 
 
USA

Mesoblast

 
 
USA

Metacrine Inc

 
Japan

Metcela Inc.

 
 
USA

Meyers Investments Family Lp

 
United Kingdom

MGB Biopharma

 
USA

MichBio

 
 
Japan

Microbialchem

 
United Kingdom

Microbiotica

 
 
USA

Migraine.AI

 
Japan

Miibio,Inc.

 
Germany

Miltenyi Biotec

 
United Kingdom

MIP Diagnostics Ltd

 
United Kingdom

Mironid

 
Luxembourg

Mitotech S.A.

 
USA

Mitsubishi Tanabe Pharma Corp

 
USA

Mitsubishi Tanabe Pharma Corporatio

 
 
Japan

Mitsui Fudosan Co., LTD.

 
 
USA

Mitsui Global Investment

 
 
USA

Mizuho Securities USA LLC

 
 
United Kingdom

MMC Ventures

 
Japan

Mochida Pharmaceutical Co Ltd

 
 
United Kingdom

Momentum Biotech

 
 
USA

Montrose capital Partners

 
 
USA

Moore Venture Partners

 
 
United Kingdom

Morgan Prestwich

 
 
China

Morningside Ventures

 
 
USA

MP Healthcare Venture Mgmt Inc

 
 
USA

MPM Capital

 
 
USA

MVP Capital Partners

 
 
Japan

MycHunter Therapeutics

 
 
USA

Nammi Therapeutics

 
United Kingdom

Nanomerics

 
 
USA

NanoView Biosciences

 
USA

National Institute on Aging

 
 
USA

Nature Biotechnology

 
USA

Navidea Biopharmaceuticals

 
USA

Navigen

 
 
USA

NCL Technology Ventures

 
 
Sweden

NDA Group

 
United Kingdom

Neem Biotech Ltd

 
 
USA

NeoImmuneTech

 
 
United Kingdom

NeRRe Therapeutics

 
 
South Korea

NetTargets

 
 
USA

NeuBase Therapeutics

 
Australia

Neuclone

 
 
USA

Neumentum

 
Canada

Neurolign Technologies Inc.

 
 
Australia

Neuroscience Trials Australia

 
 
USA

Neurotech Reports

 
Sweden

NeuroVive Pharmaceutical AB

 
 
USA

New Perspectives Inc

 
 
USA

New Science Ventures

 
 
Japan

Newton Biocapital

 
South Korea

Nextgen Bioscience

 
South Korea

NIBEC

 
 
USA

Nieuw Amsterdam Advisors

 
Japan

Nobelpharma Co., Ltd.

 
 
USA

Noble Life Science Partners

 
Hong Kong

Nomura International HK Ltd

 
Germany

Nordmark Arzneimittel GmbH & Co. KG

 
Switzerland

Novaremed AG

 
China

Novartis

 
 
USA

Novian Health

 
USA

Novo Nordisk

 
 
Australia

Novotech

 
 
USA

Novotech CRO

 
 
USA

NSIP LLC

 
 
Australia

Nucleus Network

 
 
Canada

Nucro-Technics

 
 
Puerto Rico

Oasis Capital, LLC

 
 
Sweden

Oasmia Pharmaceutical AB

 
 
Israel

Omnix Medical

 
 
USA

OncoCellMDx, Inc.

 
 
South Korea

Oncocross Co Ltd

 
France

Oncodesign

 
 
Switzerland

Onelife Fund

 
USA

ONL Therapeutics, Inc.

 
 
USA

OptiKira, LLC

 
 
United Kingdom

Optum Ventures

 
 
USA

Opus Biotech Communications

 
United Kingdom

Orbit Discovery Ltd

 
 
USA

Oresund Capital LLC

 
 
Germany

Oryx GmbH & Co KG

 
France

Osivax

 
 
Canada

Ovensa Inc.

 
United Kingdom

OxStem Limited

 
Belgium

Oxurion NV

 
New Zealand

Pacific Edge Limited

 
 
USA

Pact & Partners Recruitments

 
 
USA

Pacylex Pharmaceuticals

 
 
USA

Panacea Venture

 
 
Italy

Panakes Partners

 
 
USA

Pandect Bioventures

 
 
Canada

Pangaea Ventures

 
USA

Panorama Medicine

 
 
USA

Pappas Capital

 
Finland

Paras Biopharmaceuticals Finland OY

 
 
USA

Particular Ventures

 
 
Canada

Partner International Inc.

 
 
USA

Partnering Insight

 
 
USA

Pathway Bioventures

 
 
USA

PBM Capital Group

 
 
USA

Peak One Investments, LLC

 
USA

PeproMene Bio

 
South Korea

Peptron Inc

 
France

Perha Pharmaceuticals

 
 
USA

Pfenex Inc

 
 
Austria

PhagoMed Biopharma GmbH

 
 
USA

PharmaCatalyst LLC

 
 
USA

Pharmadirections

 
 
China

PharmaDJ

 
France

Pharmaleads

 
USA

Philips Healthcare

 
 
USA

Phio Pharmaceuticals

 
 
USA

Photon Fund

 
 
USA

PhotonPharma, Inc

 
 
Canada

PI Financial Corp

 
USA

Pin Therapeutics

 
 
USA

Piper Jaffray & Co

 
 
Spain

Pivotal

 
 
USA

PLx Pharma

 
United Kingdom

Pneumagen Ltd

 
 
USA

PoC Capital LLC

 
 
Switzerland

Polyneuron Pharmaceuticals AG

 
 
USA

PolyPeptide Group

 
 
Switzerland

Polyphor AG

 
USA

POP Biotechnologies

 
 
China

PPC

 
 
USA

PRA Health Sciences

 
 
USA

PRECISION FOR MEDICINE

 
USA

Preclinical GPS

 
 
South Korea

Premier Partners LLC

 
Australia

Prescient Therapeutics

 
 
USA

Prevail Partners

 
 
Germany

Profil GmbH

 
United Kingdom

Prokarium

 
 
USA

ProMed Partners, LP

 
 
Poland

Proteon Pharmaceuticals S.A.

 
 
USA

Proteus Venture Partners

 
 
USA

ProTrials Research Inc

 
France

Provepharm Life Solutions

 
 
USA

Pullan Consulting

 
USA

Pyramid Biosciences, Inc

 
 
Australia

QBiotics Group Ltd

 
 
USA

Qiming Venture Partners

 
France

Quantum Genomics

 
 
Australia

QUE Oncology

 
Argentina

RADBIO

 
USA

Radius Health

 
USA

Rady Children's Institute

 
 
USA

Rallybio

 
 
United Kingdom

Random42 Scientific Communication

 
 
Canada

Raymond James

 
 
USA

Red Tailed Hawk Venture Partners

 
 
USA

RedCrow Capital

 
 
USA

Reed-Ventures

 
 
USA

Refuge Biotech

 
Russian Fed.

Regeus

 
USA

Regis Custom Pharma

 
 
Canada

Relentless Venture Fund

 
 
USA

Reneo Pharmaceuticals Inc

 
 
USA

Rethink Impact

 
 
USA

Rezolute

 
 
USA

Rho World

 
 
USA

Rithm Health

 
 
USA

Rockefeller Capital Management

 
USA

Rockwell Medical

 
 
USA

Rockwell Medical, Inc.

 
 
Germany

ROI Verwaltungsgesellschaft GmbH

 
 
USA

Roswell Biotechnologies Inc

 
 
United Kingdom

RT Partners

 
 
USA

Russo Partners LLC

 
 
United Kingdom

RYSE Asset Management

 
USA

Sabin Vaccine Institute

 
 
United Kingdom

Sachs Associates

 
South Korea

Samsung Biologics

 
USA

Samyang BioPharm USA

 
 
USA

San Diego Union-Tribune

 
USA

Sana Health Inc

 
United Kingdom

Sanger Institute

 
 
USA

Sapience Therapeutics

 
United Kingdom

Sareum Ltd

 
 
USA

Satter Investment Management

 
 
USA

Science and Medicine Group

 
Australia

Scientia Clinical Research

 
 
USA

Scotasian Capital

 
 
USA

Scrip/The Pink Sheet

 
 
USA

SDL Ventures LLC

 
 
Canada

Sectoral Asset Managemenet

 
France

Selenium Medical

 
 
USA

SELLAS Life Sciences Group

 
Latvia

Semantic Intelligence, LLC

 
France

Servier

 
USA

Servier BioInnovation

 
 
South Korea

SevenTreeEquityPartners

 
 
France

Seventure Partners

 
 
USA

ShangBay Capital

 
 
USA

ShareVault

 
 
USA

SHAW STRATEGIC CAPITAL

 
 
China

Shenzhen Lucky Source Investment Ma

 
 
China

Shenzhen Lucky Source Investment Management Corporation

 
 
Japan

Shinsei Capital Partners, Ltd.

 
 
USA

Shinyusha Publishing

 
 
USA

Shuttle Pharmaceuticals

 
France

Signia Therapeutics

 
 
USA

Silicon Valley Bank

 
Russian Fed.

Skolkovo Foundation

 
 
USA

SmartLabs

 
 
South Korea

SM-Sino Technology Investment

 
 
Canada

Sofinnova Investments

 
Spain

SOM BIOTECH S.L

 
 
United Kingdom

Somanauitx

 
United Kingdom

SomaServe

 
USA

Sonavex, Inc.

 
 
Australia

Southern Star Research

 
South Korea

SPARK Biopharma

 
Saudi Arabia

Spimaco Addwaeih

 
Sweden

Sprint Bioscience

 
 
USA

Stadius BioPharma.com

 
 
Israel

Star Tree Ventures

 
Austria

S-TARget therapeutics Gmbh

 
 
USA

STATKING Clinical Services

 
 
USA

StemBioSys

 
 
France

Step Pharma

 
USA

Strand Therapeutics

 
USA

Stuart Therapeutics, Inc.

 
USA

Sunovion Pharmaceuticals Inc

 
 
Denmark

Sunstone Life Science Ventures A/S

 
France

Surgivisio

 
 
USA

SVB Capital

 
 
USA

SVB Leerink

 
Taiwan

SynCore Biotechnology Co Ltd

 
USA

Syneos Health

 
Belgium

Syngulon

 
 
USA

Syno Capital

 
United Kingdom

SYNthesis Research

 
 
USA

SYZYGY THERAPEUTICS

 
 
USA

Tactics II Equity LLC

 
 
USA

Talfinium Investments Inc

 
 
USA

TARA Biosystems

 
USA

Target Health Inc

 
 
Australia

Tarnagulla Ventures Pty Ltd

 
 
USA

Tarveda Therapeutics

 
USA

TCI Peptide Therapeutics

 
 
USA

TCR

 
 
USA

Tech Coast Angels San Diego

 
 
USA

Tech.Bio Fund

 
United Kingdom

Teijin Pharma Limited

 
 
Canada

Teralys Capital

 
 
USA

The Benchmark Company LLC

 
 
USA

The Channel Group

 
 
USA

The FreeMind Group

 
United Kingdom

The Institute of Cancer Research

 
 
USA

The Sage Group Inc

 
France

Theranexus

 
Canada

TheraPten Biosciences Inc

 
Canada

Therapure Biopharma Inc

 
Japan

ThinkCyte

 
 
USA

Third Pole Therapeutics

 
 
USA

Thrive Bioscience, Inc.

 
 
Netherlands

Thuja Capital Management

 
France

Tilak Healthcare

 
Finland

TILT Biotherapeutics

 
 
USA

Timmerman Report

 
 
USA

Tonix Pharmaceuticals Holding Corp.

 
USA

Tools4Patient

 
Belgium

Tools4Patient S A

 
 
USA

Travera

 
 
USA

Triangle Insights Group LLC

 
 
USA

Tribeca Companies

 
 
Germany

TRINITY Life Sciences

 
 
USA

Trinity Partners

 
USA

TriSalus Life Sciences

 
 
USA

Trovagene Inc

 
USA

Tulane University

 
Japan

Tupac.Bio

 
 
Canada

TVM Life Science Management Inc

 
 
USA

Two Sigma Ventures

 
 
USA

UCB Ventures

 
USA

UNC OTC

 
USA

University of Michigan

 
USA

UPMC Enterprises

 
France

Urgo RID

 
France

UROMEMS

 
 
USA

UT Horizon Fund

 
Japan

UTokyo Innovation Platform Co., Ltd

 
 
USA

V2M Capital LLC

 
 
USA

Valley Fever Solutions

 
 
USA

Vallon Pharmaceuticals

 
 
United Kingdom

Valo Therapeutics Ltd

 
 
USA

VasoRx, Inc.

 
 
USA

Vaxess Technologies

 
Switzerland

Vaximm AG

 
 
Belgium

V-Bio Ventures

 
 
USA

Venrock

 
 
USA

Verndari Inc.

 
Switzerland

Versantis AG

 
 
Luxembourg

Vesalius Biocapital III

 
USA

VGSK Technologies

 
 
USA

ViaCyte Inc

 
 
USA

Vickers Venture Partners

 
USA

Viela Bio Inc

 
 
USA

Viking Therapeutics

 
USA

Vincere Biosciences

 
Netherlands

Viroclinics Biosciences BV

 
United Kingdom

Virokine Therapeutics Ltd

 
 
USA

Virtual Health Partners

 
 
Luxembourg

VitaTech SA

 
 
China

Viva BioInnovator

 
Germany

Vivoryon Therapeutics AG

 
USA

Vyome Therapeutics Inc

 
 
USA

W Global Capital Limited

 
 
USA

Wavemaker Three-Sixty Health

 
 
USA

WBB Securities LLC

 
 
Japan

Whiz Partners Inc

 
 
USA

WI Harper Group

 
 
Canada

WinnerMax Capital

 
 
USA

Winning Difference

 
Canada

Winterlight Labs

 
 
China

Wondfo Biotech

 
 
USA

WRF Capital

 
 
USA

WuXi Biologics

 
 
USA

www.affinitygrowth.com

 
 
Israel

www.biolinerx.com

 
USA

www.felixbt.com

 
 
Malaysia

Xeraya Capital

 
 
Denmark

Xplico ApS

 
USA

Xsphera Biosciences Inc

 
USA

Xyphos Biosciences Inc

 
 
USA

Yale University

 
South Korea

Y-Biologics

 
 
USA

Yonjin Capital

 
 
USA

Yorkville Advisors

 
USA

YourChoice Therapeutics

 
South Korea

Yungjin Pharmaceuticals. Co. Ltd.

 
 
Australia

Yuuwa Capital LP

 
 
USA

Zacks Investment Research

 
 
USA

Zimmons International Communication

 
 
USA

ZJ Future